Obesity is a complex, chronic disease and global public health challenge. Characterized by
excessive fat accumulation in the body, obesity sharply increases the risk of several …

The incretin hormone Glucagon-Like Peptide-1 (GLP-1) is best known for its “incretin effect”
in restoring glucose homeostasis in diabetics, however, it is now apparent that it has a …

Glucagon-like peptide 1 receptor (GLP-1R) and glucose-dependent insulinotropic
polypeptide receptor (GIPR) are two class B1 G protein-coupled receptors, which are …

Abstract Background Type 2 diabetes (T2D), one of the major common human health
problems, is growing at an alarming rate around the globe. Alpha-glucosidase and …

Abstract Glucagon-like peptide-1 (7–36) amide (GLP-1) is a secreted peptide that acts as a
key determinant of blood glucose homeostasis by virtue of its abilities to slow gastric …

Consumption of milk and dairy products has been associated with reduced risk of metabolic
disorders and cardiovascular disease. Milk contains two primary sources of protein, casein …

Sažetak Diabetes is a complex, heterogeneous condition that has beta cell dysfunction at its
core. Many factors (eg hyperglycemia/glucotoxicity, lipotoxicity, autoimmunity, inflammation …

The intrahepatic milieu is inhospitable to intraportal islet allografts,–, limiting their
applicability for the treatment of type 1 diabetes. Although the subcutaneous space …

Our work is aimed at unraveling the role of the first-phase insulin secretion in the natural
history of type 2 diabetes mellitus (T2DM) and its interrelationship with insulin resistance …

Diabetes is one of the chronic metabolic disorders which poses a multitude of life-
debilitating challenges, including cardiac muscle impairment, which eventually results in …